Speaker
Prof. Roel VERHAAK
Professor and Associate Director for Computational Biology, The Jackson Laboratory for Genomic Medicine
Abstract
The highly lethal nature of glioma results in a huge year of potential life lost cost. High throughput sequencing has identified somatic alterations in primary disease but these have been hard to target, and as a result improvement in clinical outcomes has lagged behind compared to other cancers. An improved understanding of the mechanisms of glioma progression is needed to develop higher efficacy therapies. Through sequencing of patient tumors and model systems, we show how the glioma genotype and phenotype evolves over time.”
Please register by sending a mail to florence.henry@lih.lu